Dr. Olivier Gerbault's Private Practice
| フランス | トルコ | オーストリア | |
| 血漿交換術 | から $1,800 | から $1,200 | から $2,000 |
| クルクミン点滴 | から $750 | から $350 | から $350 |
| 選択的アフェレーシス | - | から $1,550 | - |
| 血漿交換 | - | から $3,900 | - |
| 治療的アフェレーシス | - | から $1,350 | - |
Bookimedは免疫学治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。免疫学治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。免疫学治療の旅路でお一人になることはありません。
France treats autoimmune diseases through a network of university hospitals (CHU) and certified reference centers. The national FAI2R network coordinates over 80 expert sites. Leading facilities include Hôpital Cochin and Hôpital Pitié-Salpêtrière in Paris, alongside specialized interdisciplinary hubs in Montpellier and Lyon.
Bookimed Expert Insight: French university hospitals prioritize interdisciplinary care for rare conditions. Data shows specialized centers in Montpellier, like the Immun4Cure institute, integrate research directly into clinical practice. Patients benefit from these academic environments where specialists manage complex diagnostics alongside active clinical trials.
Patient Consensus: Patients recommend using hospital-based care over private clinics for better insurance coverage. They suggest bringing complete medical records to ensure specialists can provide an effective treatment plan.
France manages advanced immunotherapies through a centralized, state-regulated framework. The Haute Autorité de Santé (HAS) provides early access to CAR-T therapies via the AAP system. This mechanism bypasses standard pricing delays for urgent hematological cases. Highly specialized, certified academic centers handle all clinical administration.
Bookimed Expert Insight: French immunology centers utilize a decentralized preparatory model to optimize resource use. While academic hubs handle complex cell engineering, regional partners often manage initial chemotherapy steps. This integration between public labs and regional hospitals maintains high patient volumes without overloading specialized beds.
Patient Consensus: These therapies require intensive hospital stays in large tertiary centers due to potential side effects. Patients note that staying near the facility is vital for monitoring after the infusion process.
France manages CIDP and immune deficiencies through standardized national protocols called PNDS. Treatment utilizes intravenous or subcutaneous immunoglobulins to prevent nerve damage and infections. The national health system typically covers these essential therapies. Specialized hospital reference centers oversee prescription safety and product traceability.
Bookimed Expert Insight: French immunology centers prioritize transitioning stable patients to subcutaneous SCIg therapy. This shift typically reduces hospital visits while maintaining steady IgG serum levels. Our data shows that initial consultations for treatment planning in France range from $200 to $300.
Patient Consensus: Patients note that immunoglobulin therapy is a long-term commitment rather than a quick cure. Many emphasize that keeping a strict infusion schedule is vital to prevent weakness from returning between doses.
Allergen immunotherapy is a primary treatment for respiratory allergies and venom hypersensitivity in France. The national health system, Assurance Maladie, routinely covers these desensitization protocols. Specialists favor sublingual methods for safety. Patients typically combine public coverage with private insurance to manage costs.
Bookimed Expert Insight: Immunology consultations in France start from $100. While the system is supportive, international patients should note that reimbursement depends on social security enrollment. Public coverage is not automatic for new arrivals. We recommend bringing detailed records to match specific allergen molecules available locally.
Patient Consensus: Patients note that the public system is very supportive of long-term therapy. However, many emphasize that enrolling in social security is a slow, bureaucratic process for newcomers.